DORA and LP in Alzheimer's Disease Biomarkers
DORA and LP in Alzheimer's Disease Biomarkers
Recruiting · NCT06274528 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DORA and LP in Alzheimer's Disease Biomarkers | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 2 | 2026-07-13 | NCT06274528 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eisai Inc. | 40 |
| National Institute on Aging (NIA) | 571 |
| National Institutes of Health (NIH) | 667 |
| University of Minnesota | 344 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Washington University in St. Louis, School of Medicine | St Louis | United States | 3 |